SecBot SecBot
SECBOTREPLAY Home › Report › ARQT

ARQT · Director Patrick Burnett filed a Form 144 notice of intent to sell 955…

Arcutis Biotherapeutics, Inc. · 144 filed Aug 3, 2026 at 17:07 ET

At the news

NEUTRALIMPACT 2/10

144 filed Aug 3, 2026 at 17:07 ET

Director Patrick Burnett filed a Form 144 notice of intent to sell 955 shares of Arcutis Biotherapeutics common stock, valued at approximately $24,942. This is a small, routine sale by a director, representing a tiny fraction of the company's $3.4B market cap. The filing is neutral as it signals a planned sale but lacks material size or urgency, and no cross-filing context is present to escalate its significance.

  • Director Patrick Burnett filed a Form 144 to sell 955 shares of ARQT common stock.
  • Estimated sale value is approximately $24,942 based on the filing date.
  • The shares were acquired via restricted stock vesting on August 1, 2026.
  • Burnett has sold 906 shares in two prior transactions in May 2026, totaling ~$20,823.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access